Exercise program aims to boost Well-Being in myeloma patients
NCT ID NCT07547007
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether a 6-month, personalized exercise program can improve the quality of life for people with multiple myeloma. The program mixes in-person sessions at the hospital with at-home workouts. Researchers will compare participants who get the exercise program to those who only receive advice about physical activity. The goal is to see if the program helps with pain, energy, and overall well-being.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
adapted physical activity program
What this could lead to
If it works, this could show that a personalized exercise program helps multiple myeloma patients feel better and have a higher quality of life during treatment.
What could go wrong
This is a small, early-stage trial with only 86 participants. The exercise program may be difficult for some patients to follow, and the results might not apply to all myeloma patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA (MM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CH Annecy Genevois
RECRUITINGAnnecy, 74374, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CH Métropole Savoie
RECRUITINGChambéry, 73000, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••